Abstract
We have purified and characterized a bovine brain pentaglycosylceramide as Lewis X and identified it in human and rat brain using anti-Lewis X (anti-SSEA 1) monoclonal antibody. Neutral glycosphingolipid expression in developing rat brain has been examined by digoxigenin immunostaining and TLC-immunostaining using anti-SSEA 1 and anti-GgOse4Cer (GA1) monoclonal antibodies. Five transient Lewis X-series bands were identified in brain at embryonic day 15 that disappear by postnatal day 5 (one disappears at embryonic day 18). Gangliotetraosylceramide (GA1) first appears at embryonic day 21 and increases in concentration with age until postnatal day 21. In addition, we have purified another minor brain neutral glycosphingolipid and tentatively identified it as a Lewis X-series glycolipid by gas chromatography-mass spectrometry analysis followed by TLC-immunostaining with anti-SSEA 1 antibody.
Similar content being viewed by others
Abbreviations
- Cer:
-
Ceramide, GlcCer, Glcβ1-1Cer
- LacCer:
-
Galβ1-4GlcCer
- CTH:
-
Galα1-4LacCer
- nLcOse4Cer:
-
Galβ1-4GlcNAcβ1-3LacCer
- nLcOse5Cer:
-
Galα1-3nLcOse4Cer
- GgOse4Cer:
-
Galβ1-3GalNAcβ1-4LacCer
- DPA:
-
diphenylamine-aniline-phosphoric acid
- SSEA:
-
stage-specific embryonic antigen
- NGSL:
-
neutral glycosphingolipid
- TLC:
-
thin-layer tomography
- HPTLC:
-
high performance thin-layer chromatography
- GA1:
-
gangliotetraosyleramide
- SAT-2:
-
sialytransferase-2
- GalNAcT-1:
-
galactosaminyltransferase-1
- DIG-IS:
-
digoxigenin-immunostaining
- PMAAS:
-
partially methylated alditol acetates
- DCE:
-
dichloroethane
- TLC-IS:
-
TLC-immunostaining
- (Lex):
-
Lewis X
- NK:
-
murine natural killer
References
Berra B, Cestaro B, Sale OF, Venerando B, Beltreme D, Cantone A (1978)Bull Mol Biol Med 3: 86–97.
Irwin LN, Michael DB, Irwin CC (1980)J Neurochem 34: 1527–30.
Hilbig R, Rosner H, Merz G, Segler-Stahl K, Rahman H (1982)Rouxs Arch Dev Biol 191: 281–82.
Izumi T, Ogawa T, Koizumi H, Fukuyama Y (1993)Pediatr Neurol 9: 297–300.
Igarashi M, Waki H, Saito S, Komiya Y, Ando S (1994)Brain Res 78: 17–24.
Yu RK (1994)Prog Brain Res 101: 31–44.
Yu RK, Macala LJ, Taki T, Wienfield H, Yu FS (1988)J Neurochem 50: 1825–29.
Ullman MD, McCluer RH (1977)Trans Am Soc Neurochem 8: 189.
Fukushi Y, Hakomori SI, Shephard T (1984)J Exp Med 159: 506–20.
Kniep B, Muhlradt PF (1990)Analyt Biochem 188: 5–8.
Dasgupta S, Hogan EL (1993)Ind J Biochem Biophys 30: 341–45.
Dasgupta S, Van Halbeek H, Hogan EL (1992)FEBS Lett 301: 141–44.
Dasgupta S, Hogan EL (1991)Trans Am Soc Neurochem 22: 145.
Dasgupta S, Hogan EL, Van Halbeek H (1995)J Neurochem 65: 2344–49.
Li SC, Mazotta MY, Chien SF, Li YT (1975)J Biol Chem 250: 6786–91.
Li SC, Li YT (1970)J Biol Chem 245: 8934–42.
Dasgupta S, Chien JL, Hogan EL, Van Halbeek H (1991)J Lipid Res 32: 499–506.
Gunnarson A (1987)Glycoconjugate J 4: 239–45.
Bjorndal H, Lindberg B, Svensson S (1967)Acta Chem Scand 21: 1801–4.
Levery SB, Weiss JB, Salyan MEK, Roberts CE, Hakomori SI, Magnani JL, Stroud M (1992)J Biol Chem 267: 5542–51.
Saito T, Hakomori SI (1971)J Lipid Res 12: 257–59.
Kusunoki S, Tsuji S, Nagai Y (1985)Brain Res 334: 117–24.
Taki T, Abe M, Matsumoto M (1982)J Biochem (Tokyo) 5: 1813–16.
Dasgupta S, Cashwell JM, Terry EC, Hogan EL (1995)J Neurochem 64: S88.
Nair SM, Prasadrao N, Tobet SA, Jungalwala FB (1993)J Comp Neurol 332: 282–92.
Basu M, De T, Das KK, Kyle JW, Chou HC, Schaeper RJ, Basu S (1987) InMethods Enzymol (Ginsburg V ed.) NY: Academic Press,138: 575–607.
Dasgupta S, Chien JL, Hogan EL (1986)Biochim Biophys Acta 876: 363–70.
Dasgupta S, Chien JL, Hogan EL (1990)Biochim Biophys Acta 1036: 11–17.
Troost J, van der Heijnden MCM, Staal GEJ (1976)Biochim Biophys Acta 73: 329–46.
McKibbin JM (1978)J Lipid Res 19: 131–47.
Vanier MT, Mansson JE, Svennerholm L (1980)FEBS Lett 112: 70–72.
Ishikawa Y, Shinsei G, Minami R, Makita A (1987)J Biochem (Tokyo) 101: 1369–75.
Fenderson BA, Holmes EH, Fukushi Y, Hakomori SI (1986)Dev Biol 114: 12–21.
Fenderson BA, Andrews PW, Nudelman E, Clausen H, Hakomori SI (1987)Dev Biol 122: 21–34.
Fenderson BA, Eddy EM, Hakomori SI (1988)Differentiation 38: 124–33.
Eggens I, Fenderson B, Toyokuni T, Dean B, Stroud M, Hakomori SI (1989)J Biol Chem 264: 9476–84.
Yamamoto M, Boyer A, Schwarting G (1985)Proc Natl Acad Sci USA 82: 3045–49.
Young WW Jr, Hakomori SI, Durdik JM, Henney CS (1980)J Immunol 124: 199–201.
Kasai M, Nagai Y, Okumura K, Tada T (1980)Eur J Immunol 10: 175–80.
Baba H, Daune GC, Ilyas AA, Pestronk A, Cornblath DR, Chaudhury V, Griffin JM, Quarles RH (1989)J Neuroimmunol 25: 143–50.
Marcus DM, Perry L, Gilbert S, Preud'homme JL, Kyle R (1989)J Immunol 14: 2929–32.
Marcus DM (1989)Ann Neurol 27: S53–55.
Yoshino H, Miyashita K, Miyatani N, Ariga T, Hashimoto Y, Tsuji S, Oyanagi K, Ohama E, Ikuta F, Suzuki K, Miyatake T (1990)J Neurol Sci 97: 53–65.
Ilyas AA, Mithen FA, Chen ZW, Cook SD (1991)J Neurol Sci 102: 67–75.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dasgupta, S., Hogan, E.L. & Spicer, S.S. Stage-specific expression of fuco-neolacto- (Lewis X) and ganglio-series neutral glycosphingolipids during brain development: characterization of Lewis X and related glycosphingolipids in bovine, human and rat brain. Glycoconjugate J 13, 367–375 (1996). https://doi.org/10.1007/BF00731469
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731469